local_hospital

Wielospecjalistyczny Szpital Miejski Im. Jozefa Strusia Z Zakladem Opiekunczo Leczniczym. Samodzielny Publiczny Zaklad Opieki Zdrowotnej Z Siedziba W Poznaniu Przy Ul. Szwajcarskiej 3

Address
Ul. Szwajcarska 3, 61-285 Poznan, Poland

Wielospecjalistyczny Szpital Miejski Im. Jozefa Strusia - Hematology Research Center

This multi-specialty municipal hospital in Poznań serves as a specialized research center for advanced hematological disorders, with particular expertise in myeloproliferative neoplasms. The facility participates in cutting-edge clinical trials providing extended access to novel therapeutic agents for patients with rare blood cancers.

  • Primary Myelofibrosis (PMF) treatment and long-term management
  • Post-Polycythemia Vera Myelofibrosis research
  • Post-Essential Thrombocythemia Myelofibrosis studies

The center's research program focuses on evaluating long-term safety profiles of investigational medications, including momelotinib therapy for patients with myelofibrosis who demonstrate stable disease without progression. Their participation in extended access studies ensures continued treatment availability for patients benefiting from experimental therapies while contributing valuable data on sustained efficacy and safety outcomes in myeloproliferative disorders.

Site Overview

assignment
2
connected trials
corporate_fare
3
sponsors
science
3
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
3
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
2
Outperforms 43% of sites
public
Therapeutic diversity
2areas
Outperforms 53% of sites
groups
Sponsor diversity
3sponsors
Outperforms 58% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Wielospecjalistyczny Szpital Miejski Im. Jozefa Strusia Z Zakladem Opiekunczo Leczniczym. Samodzielny Publiczny Zaklad Opieki Zdrowotnej Z Siedziba W Poznaniu Przy Ul. Szwajcarskiej 3

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Low-Dose Acetylsalicylic Acid Plus Prasugrel Versus Low- and High-Dose Acetylsalicylic Acid on Graft Patency in Stable Coronary Artery Disease Post-CABGAgencja Badań Medycznych, Dolnoslaskie Centrum Chorob Serca Im. Prof. Zbigniewa Religi Medinet Sp. z o.o.Phase IIIRecruitingNov 2025

IMP list

lock Showing 1 of 3 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Acetylsalicylic Acid1Unknown2025-11-242025-11-24

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.